Retatrutide Vial

32mg

Retatrutide is an investigational once-weekly peptide designed to activate three metabolic hormone receptors: GIP, GLP-1 and glucagon. By targeting these pathways simultaneously, retatrutide is being studied for its potential effects on appetite regulation, energy metabolism, blood glucose control and body-weight reduction. Clinical research has demonstrated substantial weight loss in adults with obesity, while ongoing Phase 3 studies continue to evaluate its longer-term efficacy and safety.

For research purposes only. Not for human consumption. You must be 18 or older to purchase.